CLINICAL_TRIALS
trial_result
· 2021-09-14
Clinical Trial Update: Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma [Phase 2]
Summary
A Phase 2 trial comparing IMCgp100 against investigator's choice in advanced uveal melanoma completed, with results posted in September 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Immunocore Ltd | Conditions: Uveal Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2021-09-14